Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Optimizing laser therapy doses for knee osteoarthritis pain relief

Official title: Optimal High-Intensity Laser Therapy (HILT) Parameters for Pain and Function in Patients With Moderate Knee Osteoarthritis: A Randomized Controlled Trial

Run by Al Hayah University In Cairo · NCT06916676 · Data updated 2026-11-12

This study is testing different doses of laser therapy to see which one helps people aged 45 to 75 with knee osteoarthritis feel less pain and move better.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment140 (estimated)
SponsorAl Hayah University In Cairo
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedApril 23, 2025
Main results expectedMarch 1, 2027
Study endsJune 1, 2027
Registry record updatedApril 8, 2025
Trial IDNCT06916676 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 45 to 75 with a clinical diagnosis of knee osteoarthritis and moderate pain levels.

Probably not a fit

Patients with inflammatory arthritis or those who have had recent knee surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to determine the most effective doses of High-Intensity Laser Therapy (HILT) for alleviating pain and enhancing function in individuals suffering from moderate knee osteoarthritis. Participants aged 45 to 75 will be randomly assigned to receive one of three different doses of HILT or a placebo treatment, administered three times a week over four weeks. The primary outcomes will focus on changes in knee pain levels and functional ability, assessed through a pain scale and a questionnaire. This approach seeks to identify the optimal therapeutic dose for improved patient outcomes.

Why it matters

Potential benefit: If successful, this study could provide a non-invasive treatment option that significantly reduces knee pain and improves function for patients with osteoarthritis.

How similar studies have gone: While there is ongoing research into laser therapies for pain management, this specific dose optimization approach is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age between 45 and 75 years, inclusive. Clinical diagnosis of knee osteoarthritis according to American College of Rheumatology (ACR) criteria (knee pain plus at least 3 of 6: age \>50, morning stiffness \<30 min, crepitus, bony tenderness, bony enlargement, no palpable warmth).

Radiographic evidence of knee osteoarthritis corresponding to Kellgren-Lawrence grade II or III in the target knee.

Average knee pain intensity ≥ 4 on a 10-cm Visual Analogue Scale (VAS) during weight-bearing activities in the past week.

Willingness and ability to attend 3 sessions per week for 4 weeks and attend all assessment sessions.

Exclusion Criteria:

Previous surgery on the index knee (including arthroscopy within the last year or joint replacement).

Diagnosis of inflammatory arthritis (e.g., rheumatoid arthritis, psoriatic arthritis, gout).

Intra-articular corticosteroid or hyaluronic acid injection in the index knee within the last 3 months.

Clinically significant comorbidities that could interfere with participation or assessment (e.g., severe uncontrolled cardiovascular disease, severe pulmonary disease, significant neurological deficits affecting the lower limb).

Presence of skin conditions (e.g., infection, open wounds, eczema, photosensitivity disorders) in the area designated for laser treatment.

Current use of anticoagulant medication (e.g., warfarin, DOACs) due to potential risk, unless stable and cleared by physician. (Consider if this is truly necessary based on HILT mechanism).

History of cancer in the treatment area or active malignancy elsewhere. Known photosensitivity or use of photosensitizing medications. Pregnancy, planning pregnancy, or breastfeeding. Participation in another interventional clinical trial within the last 30 days. Inability to understand or communicate in the study language.

Where it's running

  • Faculty of Physical Therapy, Al Hayah University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.